Former Playboy star Kendra Wilkinson revealed that she started taking a weight-loss drug but threw the medication away after ...

Eli Lilly GLP-1 pill orforglipron could revolutionize the weight loss world by the end of 2025 after promising Phase 3 trial ...

Pfizer’s announcement that it will stop developing its oral weight-loss drug gave shares of Wegovy maker Novo Nordisk and ...

Although it isn't the largest therapeutic area in the pharmaceutical industry, the market for weight loss therapies has ...

U.S. pharma giant Eli Lilly And Co (NYSE:LLY) announced the launch of its popular weight loss drug Mounjaro (tirzepatide) in ...

Eli Lilly reported promising results from a study of its experimental oral drug that could rival popular injections to treat ...

The former Playboy model, 39, started injecting the drug after being body-shamed by internet trolls earlier this year.

Lilly, which makes weight loss injections, unveils trial result showing Type 2 diabetes sufferers lost 8% of body weight ...

Appetite-suppressing medications that an estimated 10% of American adults use are disrupting grocery shopping.

Countless investors and investment advisors are losing significant money because they are stuck in the orthodox thinking that ...

but has other obesity treatments in the works so investors aren't really upset Shares of weight-loss drugmakers Novo Nordisk A/S and Eli Lilly and Co. got a nice lift Monday, after a potential ...

Pfizer halted development of its weight-loss pill, danuglipron, after liver injury concerns surfaced during trials, impacting ...